Neonatal nasal obstruction

V, Andrés Alvo; Villarroel, Galia; Sedano, Cecilia D.

doi:10.1007/s00405-020-06546-y

Cited by 17 publications

(11 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If such issues are identified, adjustments should be made, either in the design of the conformer, its wear schedule, or through alternative measures to ensure the patient's airway is not compromised. The benefits of using the conformer should be weighed against the risks of potential respiratory difficulties, and the device should be customized to meet the individual needs of each patient 22,23 . In this study, the parents of the infants included in the research did not report any respiratory anomalies.…”

Section: Discussionmentioning

confidence: 99%

Efectividad de un Moldeador Alveolar para Corrección de Colapso Nasal en Pacientes con Labio Hendido.

González Macías,

Metlich Medlich,

García García

et al. 2024

j.maxilo

View full text Add to dashboard Cite

Objective: To propose the use of a post-surgical alveolar molder in patients under 4 years of age who have undergone cheiloplasty, aiming for better aesthetic and functional outcomes, using nasal morphometric and photogrammetric studies as measurement references.Materials and methods: This is a before-and-after pilot study conducted at the Oral and Maxillofacial Surgery Service and the Plastic and Reconstructive Surgery Service of Dr.Ignacio Morones Prieto Central Hospital. Patients included in the study were those diagnosed with Cleft Lip and Palate (CLP), presenting clinical data of nasal asymmetry, and aged between 0 and 4 years. An alveolar molder was fabricated using orthodontic wire and self-polymerizing acrylic/monomer according to the size and shape of the patient's nose. The device consists of a wire device with double hooks and a double "V" that will be placed in the frontal region. The evaluation of nasal shape and symmetry was carried out through a photogrammetric study and clinical measurement of nasal height and width. Results:The study included 18 patients, aged between 4 and 39 months, of which 10 presented left-sided clefts, 5 right-sided, and 3 bilateral. The study demonstrated that the use of an alveolar molder in patients with cleft lip and palate resulted in significant improvements in nasal symmetry and morphology, evidenced by increases in vertical and angular dimensions; specifically, the PnC-SarSal distance increased from 18.61 ± 1.78 mm to 20.50 ± 1.64 mm and the height of the right nasal fossa from 6.97 ± 1.49 mm to 8.22 ± 1.68 mm, with notable angular improvements in the Nlr-Midline and Nll-Midline distances. Conclusions:The alveolar molder proposed in this study proved to be a useful tool for improving nasal symmetry and morphology in these types of patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Efectividad de un Moldeador Alveolar para Corrección de Colapso Nasal en Pacientes con Labio Hendido.

González Macías,

Metlich Medlich,

García García

et al. 2024

j.maxilo

View full text Add to dashboard Cite

show abstract

“…Nasal valve collapse is often associated with obstruction on inspiration or during exercise 381,382,385 . Some congenital anatomical abnormalities such as piriform aperture stenosis or choanal atresia also cause nasal obstruction, which typically results in lifelong symptoms, which may or may not be identified in childhood 386 . The majority of these structural conditions should be evident on a physical examination including nasal endoscopy.…”

Section: Definitions Classification and Differential Diagnosis Of All...mentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

151

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

“…While some individuals may be asymptomatic, affected persons may present with headache, facial pain or pressure, anosmia or hyposmia, chronic nasal congestion, nasal discharge, polyps, or mucosal edema. In infants, as obligate nose breathers, nasal obstruction and congestion may affect the ability to feed [ 5 ]. Olfaction dysfunction may lead to poor appetite, food aversion, and subsequently suboptimal nutritional intake.…”

Section: Sinusitismentioning

confidence: 99%

Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management

et al. 2022

View full text Add to dashboard Cite

Cystic fibrosis (CF) is a chronic, multisystem disease with multiple comorbidities that can significantly affect nutrition and quality of life. Maintaining nutritional adequacy can be challenging in people with cystic fibrosis and has been directly associated with suboptimal clinical outcomes. Comorbidities of CF can result in significantly decreased nutritional intake and intestinal absorption, as well as increased metabolic demands. It is crucial to utilize a multidisciplinary team with expertise in CF to optimize growth and nutrition, where patients with CF and their loved ones are placed in the center of the care model. Additionally, with the advent of highly effective modulators (HEMs), CF providers have begun to identify previously unrecognized nutritional issues, such as obesity. Here, we will review and summarize commonly encountered comorbidities and their nutritional impact on this unique population.

show abstract

Neonatal nasal obstruction

Cited by 17 publications

References 46 publications

Efectividad de un Moldeador Alveolar para Corrección de Colapso Nasal en Pacientes con Labio Hendido.

Efectividad de un Moldeador Alveolar para Corrección de Colapso Nasal en Pacientes con Labio Hendido.

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management

Contact Info

Product

Resources

About